Funding for this research was provided by:
Text and Data Mining valid from 2018-10-20
Received: 30 December 2017
Accepted: 26 September 2018
First Online: 20 October 2018
Ethics approval and consent to participate
: The study received approval by the Medical Ethics Committee (METC Zuid West Holland). This trial has been registered in the European Union Clinical Trials Register (EUCTR) and is conducted in compliance with the European Union Clinical Trials Directive (2001/20/EC) and the principles of the Declaration of Helsinki (2013).For eligible patients, written informed has to be obtained by their treating physician. If a patient is not capable to give written informed consent (i.e. due to altered consciousness or aphasia), the treating physician will ask the legal representative to provide written informed consent. Once the patient is capable of giving their own informed consent, the treating physician (at the ward or outpatient clinic) will ask the patient to provide written informed consent. If the patient withdraws their permission, the patient data will not be used for this study.
: By giving written informed consent, patients agree with the storage of data and publication of the study results.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.